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Background: Infections are responsible for 30–40 % of 4 million neonatal deaths annually. Use of chlorhexidine
(CHX), a broad-spectrum topical antiseptic with strong residual activity, for umbilical cord cleansing has been
shown to reduce infections during the neonatal period. However, the challenge remains with regard to selection of
best mode of CHX delivery. As a part of formative research, we undertook a qualitative study in Pemba Island as a
pilot to explore the attitudes; beliefs and practices of the community and health workers related to delivery,
newborn and cord care. During the second phase of formative research, we used Trials of Improved Practices (TIPs)
methodology to explore the acceptance and impediments, for the three possible modes of chlorhexidine
application- 100 ml bottle with cotton swab, 10 ml single use dropper bottle and 3 g single application squeeze
tube containing gel, as an umbilical cord care intervention.
Methods: In this pilot study, 204 mother-newborn pairs were enrolled from hospital and community setting in
Pemba, Tanzania using a randomized three period crossover design. Mothers/guardians, Trained Birth Attendants
(TBA)/ medical staff and community health workers (CHWs) were requested to try three different modes of CHX
application for cord cleaning. All participants were demonstrated the method of cord cleaning using all three
modes of delivery; each delivery mode was used for 3 days and an interview was conducted on day 10 to collect
summary of their experience. Acceptance and preference scores were calculated based on feedback from the
participants.
Results: Of 204 mother-newborn pairs, 27 were lost to follow up. 177 mothers performed the intervention and
applied CHX to the newborn cord for all 9 days. Mothers rated 10 ml dropper bottle (49.7 %) as most convenient
in terms of ease and application. They selected 10 ml dropper bottle (44.6 %) as their first choice; gel tube (33.9 %)
and 100 ml bottle (21.5 %) as their second and third choice. TBAs, medical staff and CHWs also preferred 10 ml
dropper bottle (43.3 %) over 100 ml bottle (12.9 %) and gel (38.8 %).
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Conclusions: Overall acceptability of CHX application for cord cleansing was high. 10 ml single use dropper bottle
was given highest preference for CHX application. An understanding of the attitudes, beliefs and cultural practices
in the community and selection of the most acceptable mode of CHX delivery is essential to the design and
implementation of the intervention trials examining the efficacy of CHX cord care in reducing neonatal mortality
and subsequent implementation in the programs.
Trial registration: ClinicalTrials.gov NCT01528852 Registered February 3, 2012
Keywords: Trials of Improved Practices (TIPs), Chlorhexidine, Cord careBackground
Neonatal mortality accounts for 70 % of deaths in the
first year and 40 % of total under-five mortality [1–3].
Each year nearly 4 million children die before 4 weeks of
age globally, of which over 1.1 million neonatal deaths
(28 %) occur in sub-Saharan Africa. Infections are re-
sponsible for 30–40 % of 4 million neonatal deaths an-
nually [1, 4–6]. Omphalitis, an infection of the umbilical
stump, resulting from colonization of the stump with
bacteria from the maternal genital tract and the environ-
ment poses a significant risk of infection and death dur-
ing the first 28 days of life. Effective interventions that
can be carried out at the household level are critically
needed to reduce neonatal infections and mortality.
WHO recommends clean and dry cord care for new-
borns born in health facilities, and at home in areas with
low neonatal mortality rates (<30 per thousand). How-
ever, they also propagate application of topical antisep-
tics to the cord stump during the first week of life - for
home deliveries in areas where the risk of bacterial in-
fection appears high (30 or more neonatal deaths per
1000 live births) [7]. Chlorhexidine is a broad-spectrum
topical antiseptic with strong residual activity. CHX has
shown a potential to reduce infections during the neo-
natal period [8, 9]. Being inexpensive, along with a
strong safety profile, CHX seems to be an ideal antisep-
tic for cord care in low-resource communities [10, 11].
In 2013, WHO added 7.1 % chlorhexidine digluconate
(delivering 4 % chlorhexidine) to its list of essential med-
icines for children [12]. Community level randomized
controlled trials in Nepal, Pakistan, and Bangladesh have
shown that applying a 4 % chlorhexidine product (7.1 %
chlorhexidine digluconate) to the umbilical cord has the
potential to save lives [13–15]. Two studies in Nepal
tested both aqueous and gel chlorhexidine formulation
and observed that gel formulation was more acceptable
and preferred than liquid solution [16, 17]. Use of 4 %
chlorhexidine umbilical cord wash as a low-cost interven-
tion can easily be scaled up and incorporated into prevent-
ive health care in sub-Saharan Africa, impacting a part of
the 1.1 million neonatal deaths and 27 million years of life
lost every year in sub-Saharan Africa [18–21].Given the promising results from recent chlorhexidine
research and an understanding of the existing practices
and beliefs related to newborn care, feasibility of imple-
menting a liquid cleansing solution and selection of the
most acceptable mode of delivery of intervention are es-
sential to the design and implementation of intervention
trials examining the efficacy of use of chlorhexidine to
clean umbilical cord of neonates in sub-Saharan Africa
and also for implementation of programs if found
efficacious.
We carried out a formative research phase before
starting of the main efficacy trial. In phase 1 of formative
research, Focus group discussions (FGD’s) and in-depth
interviews were held to understand the neonatal care
and umbilical cord care perceptions and practices in the
community; and evaluate the acceptance and barriers re-
garding the use of proposed chlorhexidine cleansing so-
lution. In the second phase, Trial of Improved Practices
(TIPs) methodology was used to ascertain the accept-
ability and preference for various possible modes of
chlorhexidine delivery for cord care among the mothers/
caretakers and health professionals. TIPs is developed by
Manoff group, and is a formative research method that
engages potential participants in the design of program
strategies and activities focused on behavior change,
wherein participants try new practices as part of their
routine over a trial period; and then provide feedback at
the end of the trial period [22]. The results of phase-1
have already been published elsewhere [23] and in this
paper we are reporting the findings of the Phase-2 of the
formative research. The findings from this phase would
be useful in the design and implementation of a cultur-
ally acceptable intervention for a large double-blind
community-based randomized controlled trial evaluating
the impact of chlorhexidine cord cleansing in first
10 days for reduction in omphalitis and neonatal mortal-
ity in Pemba, Tanzania where the signs of omphalitis ap-
pear frequently and predominantly in the first week of
life among newborns [24]. In Asia, Alam et al. [25]
adopted a similar strategy and carried out a formative
research study in Sylhet, Bangladesh to assess the umbil-
ical and skin care knowledge and practices for neonates
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pact of topical chlorhexidine cord cleansing on neonatal
mortality and omphalitis. Our pilot study will contribute
to the design of programs intending to implement
chlorhexidine cord care interventions in Africa and
elsewhere.Methods
Study area and subjects
The study was carried out in Pemba Island, Tanzania,
the smaller of the two islands of the Zanzibar archipel-
ago. All births occurring in October and November
2010 at five major hospitals (four district hospitals and
one cottage hospital) in the island and in the community
were included in the study till the desired sample size
was achieved.Ethical approval
Ethical approval for the study was obtained locally from
the Zanzibar Medical Research and Ethics Committee
(ZAMREC) and from the Johns Hopkins Bloomberg
School of Public Health Committee on Human Re-
search. Informed verbal consent was obtained from all
study participants in local language.Study procedures
From the community and maternity wards of the hospi-
tals, 204 mother-newborn pairs were enrolled to pretest
three possible modes of intervention i.e. 100 ml bottle
with cotton swab (A), 10 ml single use dropper bottle
(B) and 3 gm single application gel tube (C) using Trials
of Improved Practices (TIPs) methodology. A communi-
cation network was established with all the trained birth
attendants (TBAs), maternal and child health (MCH)
workers, hospital staff and health professionals working
on the island. Each personnel was provided with a cell
phone and a 24-hour study call center was set up at the
central office to ensure immediate and regular
communication.Data collection tools
The Research Scientists in consultation with the Princi-
pal Investigator designed the working protocol, methods
for data collection, standard operating procedures
(SOPs) and consent forms for study implementation.
Detailed questionnaires were prepared for collection of
socio-demographic information, pregnancy history, birth
characteristics, and newborn care practices at enroll-
ment, compliance information at follow up visits and
participant feedback at the evaluation visit. Log sheets
were designed to help mothers record CHX application
on daily basis by simply putting a tick mark.Training and reliability
Training sessions were organized to train the MCH staff,
TBAs, hospital staff and health workers on application
of all the three modes of intervention. This was followed
by practice session wherein each one of them practiced
CHX application on a dummy. A dry run was conducted
to ensure reliability and effective implementation of
study protocol. On scheduled visits, mothers were dem-
onstrated and instructed to apply chlorhexidine to the
tip (over the cut surface) of the cord, the stump and
around the base of the stump.
TIPs intervention
First phase of formative research (ethnography) helped
us to understand the barriers and facilitators to the
introduction of chlorhexidine as a cord care regimen,
develop communication messages, study procedures and
the framework for implementing a cord care interven-
tion based on the information gathered. TIPs phase in-
volved initial enrollment visit, two follow up visits and a
final assessment visit. Study team demonstrated the use
of different containers for CHX application to the
mother at the enrollment and follow up visits. Essential
newborn and cord care messages were given to the
mothers at each visitation. Mother’s feedback about
different containers was recorded in a standard
questionnaire.
Randomization
Two separate randomization schedules were generated
for hospitals and community births. There were 6
possible sequences of allocating the enrolled mother-
newborn pair to one of the 3-intervention modes-
100 ml bottle (A), 10 ml dropper bottle (B) or gel tube
(C). A mother-newborn pair randomized to sequence 1
(A B C) would use 100 ml bottle for first 3 days, 10 ml
single use dropper bottle for next 3 days and get tube
for the last 3 days. Other Possible sequences were (A C
B), (B A C), (B C A), (C A B) or (C B A). Each delivery
mode was used for the same period (three consecutive
days). Randomization was done using permuted block
randomization method (block length of 12) which gener-
ated a list of randomly allocated intervention sequence
against a serial number. This ensured uniform distribu-
tion of the intervention sequence (three application
methods) to one of the six possible delivery sequences.
Envelopes were prepared with serial number written on
them and the assigned intervention sequence sealed in-
side the envelope. Upon enrollment, the supervisor
opened the next envelope from the sequence and allo-
cated the enrolled mother-newborn pair to the interven-
tion sequence/pack printed inside it and applied the first
application mentioned in the slip to the child. Until the
opening of the seal of the envelope, both the supervisor/
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cation of the intervention sequences.
Enrollment in hospital
A surveillance system was established in the maternity
ward of all five major hospitals in the island. Female
hospital supervisors worked in shifts at the maternity
ward to cover all deliveries occurring from 7 AM till
8 PM at night. Deliveries occurring after 8 PM were en-
rolled the next morning. After birth the study team,
comprised of hospital staff and study supervisor,
screened the newborn for eligibility to participate in the
study. If the newborn was found eligible (not very sick,
did not need hospitalization and ICU care and without
any congenital malformation eliminating the possibility
of CHX intervention), the study procedure and purpose
was explained to the mother once she was stable. In case
the mother was deemed not fit, it was explained to the
nearest kin and their consent to participate was sought.
If the consent was obtained, the mother-newborn pair
was enrolled in the study. The hospital supervisor then
opened the envelope for the enrolled pair which con-
tained information about the intervention sequence and
the pack. The supervisor took the intervention pack out
and handed it over to the hospital staff to apply on the
cord of the baby. The hospital supervisor/hospital staff
applied CHX on the cord as per the first method men-
tioned in the sequence and also demonstrated the appli-
cation to the mother/caretaker and gave the supply for
the next 2 days. On discharge, the hospital supervisor
completed discharge slip with detailed information from
mother about the place where she will be moving after
discharge. The case was then handed over to the re-
spective district in charge for follow-up visits in the
community.
Enrollment in community
MCH/TBA informed the central information system
(CIS) for any new births occurring in the community.
CIS after getting new birth information organized a con-
ference call between the District In charge, Field Super-
visor and MCH staff responsible for that area to plan
immediate visit to that household. Field supervisor with
MCH staff visited the household of the newborn and
took consent from mother. Supervisor then opened the
envelope containing the intervention sequence and con-
tainer for that newborn. MCH staff applied the cleansing
solution to the tip, base and stump of newborn’s umbil-
ical cord and Supervisor demonstrated the application to
the mother/caretaker and gave the supply for the next
2 days. At enrollment, information was collected on SES
(socio-economic status) features, pregnancy history,
problems during delivery, birth characteristics, and new-
born care practices.Follow-up visits
Follow-up home visits were conducted by the MCH
staff/study supervisor on day 4, 7 and 10. During the
follow-up, mother was asked to put a tick on the log
sheet on the days she applied the allocated mode of
intervention. On the visit day-4 and −7, MCH staff/study
supervisor applied CHX using second and third type of
container, respectively (as per the sequence allocated).
They also demonstrated the application method for
cleaning the cord to the mother and left the containers
to be used for next 2 days with the mother. On these
visits, data on the reported use of solution by the mother
was recorded by checking the log sheet and counting the
number of used containers. In case the mother had not
applied the CHX, the study team member asked the
mother of the reason for not applying the intervention
and recorded it in the questionnaire.
Assessment visit
The household was visited on day 10 for final assess-
ment. The mother was asked about her experience of
using different delivery modes for cleaning the cord in
terms of convenience and preference for the choice of
the container i.e. how easy or difficult it was to use them
and her preferred container. The staff also recorded
number of days mother used the cleaning solution/gel
from the log sheet.
TIPs for MCH and hospital staff conducting deliveries
TBA, MCH and hospital staff undertaking the deliveries
and involved in the TIPs component of the study were
also interviewed regarding their experience and feedback
on the three different delivery methods used.
Chlorhexidine preparations
CHX solution was prepared by Galentic Pharma (India)
Pvt. Ltd. It contained chlorhexidine gluconate 20 %w/v
solution BP, polyoxyl 40 hydrogenated castor oil NF (RH
40), carmoisine, purified water BP, and isopropyl alcohol
BP. Chlorhexidine gel contained chlorhexidine gluco-
nate, hydroxyl-propyl methyl cellulose, glycerin, methyl-
paraben, propyl-paraben and purified water.
Statistical analysis
Descriptive statistics (frequencies, percentages, means
and standard deviation) were calculated, excluding miss-
ing data from the analysis. Convenience and preference
scores were calculated based on mothers, MCH’s and
hospital staff ’s feedback. A container was assigned
convenience score of ‘2’ if it was selected as most con-
venient to use, a score of ‘1’ if it was selected as conveni-
ent and a score of ‘0’ if it was difficult to use. Preference
scores were assigned based on the preference/choice of
container. A score of “2” for first preference; “1” for
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ceived a score of ‘0’. Data were analyzed using SPSS
Statistical Program Version 18.0 (SPSS, Chicago, IL).
Results
Among the 204 mother-newborn pairs, 27 were lost to
follow up primarily due to families moving out of the
area, leaving 177 pairs (87 %) who completed the 10 days
follow-up period. 17 % of the pregnant women in this
study were over 35 years of age and 24 % were illiterate.
More than half of the enrolled women were housewives
(Table 1).
TIPs for different modes of CHX delivery
Allocation of the intervention sequence (three applica-
tion methods; A-100 ml bottle, B-10 ml dropper bottle
and C-gel) to one of the six possible delivery sequences
i.e. (A B C) or (A C B) or (B A C) or (B C A) or (C A B)
or (C B A) was uniformly distributed. TIPs revealed that
in 81 % of the cases, first application of CHX occurred
within 12 h of birth and in 72 % cases within 8 h, irre-
spective of the mode.
The compliance was high; 97 % of mothers used all
the three modes of intervention. No adverse event due
to any mode of intervention was reported during the
course of study. Mothers reported little difficulty in
using three application methods (100 ml bottle – 83.1 %
reported no difficulties, 10 ml dropper bottle – 89.3 %,
Gel – 71.8 %). It was observed that an additional effort
was required to apply the gel (15.8 %); 100 ml bottleTable 1 Study participant characteristics (N = 204)
Characteristics N (%)
Age of mother
≤18 years 8 (3.9)
19–35 years 161 (78.9)
>35 years 35 (17.2)
Literacy
Mother (Illiterate) 49 (24.0)
Father (Illiterate) 37 (18.1)
Occupation
Mother (Housewife) 105 (51.5)
Father (Fishing/ Farming) 86 (42.2)
Income
Mother (None) 123 (60.3)





>8 18 (8.8)(10.7 %) and 10 ml dropper bottle (5.1 %). Gel prepar-
ation took more time to dry (7.3 %) than the other two
application methods.
Most of the mothers felt that the 10 ml dropper bottle
was most convenient to apply (49.7 %) compared to
100 ml container (19.8 %) or gel tube (32.2 %). From the
mothers’ perspective, even though cotton ball made the
application easier, single use dropper bottle was more
convenient to use than single use gel. Even when con-
venience scores were calculated, 10 ml single use drop-
per bottle was found to be more convenient by the
mothers/caretakers than 100 ml container or gel tube
(Mean convenience score for 10 ml bottle 1.4, in com-
parison to 0.8 and 0.9 for 100 ml and gel respectively).
Mothers/families selected 10 ml dropper bottle (44.6 %)
as their most preferred choice over the 100 ml bottle
(20.9 %) or gel tube (33.9 %) for cleansing the umbilical
cord of the newborn. When the different application
methods were compared, the preference score was high-
est for 10 ml single use dropper bottle (Mean preference
score 1.4 as compared to 0.8 and 0.9 for 100 ml and gel
respectively- Table 2). Mothers preferring 10 ml single
use bottle or gel tube also seem to be well aware of good
newborn care practices (Table 3). Based on the prefer-
ence score, TBAs, medical staff and CHWs preferred
10 ml dropper bottle (43.3 %) over 100 ml bottle
(12.9 %) and gel (38.8 %). Delivery sequence did not
change the preference for mode of delivery (Fig. 1).Discussion
Chlorhexidine is an inexpensive, safe and effective cord
care intervention for reducing neonatal morbidity and
mortality in low-resource settings [13–15]. The present
study evaluated the acceptance and impediments to
using chlorhexidine comparing three different modes (3
different packaging: 100 ml bottle with cotton swab,
10 ml single use dropper bottle and 3 gm single applica-
tion gel tube) of delivery for cord cleaning in terms of
acceptance, ease of use and effectiveness in covering the
target area using TIPs (Trials of Improved Practices)
methodology. The overall acceptability in terms of con-
venience and preference was high for 10 ml single use
dropper bottle; which was liked by most of the mothers,
TBA/MCH and hospital staff over 100 ml bottle and gel
tube. Despite chlorhexidine (in liquid form) being spread
over the abdomen through its use, 10 ml single use
dropper bottle was the preferred choice. Mothers did
not find much difficulty in applying the solution. The
advantage of using a crossover design was that every
mother had an experience of testing all the three modes
of delivery of chlorhexidine to apply on the umbilical
cord and could therefore perceive the risks/benefits as-
sociated with each.
Table 2 Preference and convenience scores
Preference Scores 100 ml 10 ml Gel
Mothers
Most preferred (Score 2) 37 (20.9) 79 (44.6) 60 (33.9)
Less preferred (Score 1) 60 (33.9) 69 (39.0) 48 (27.1)
Not preferred (Score 0) 80 (45.2) 29 (16.4) 60 (39.0)
Mean scores for preference ± (SD) 0.8 (0.7) 1.4 (0.7) 0.9 (0.8)
MCH Workers
Most preferred (Score 2) 12 (17.9) 26 (38.8) 29 (43.3)
Less preferred (Score 1) 11 (16.4) 30 (44.8) 26 (38.8)
Not preferred (Score 0) 44 (65.7) 11 (16.4) 12 (17.9)
Mean scores for preference ± (SD) 0.5 (0.8) 1.2 (0.7) 1.2 (0.8)
Convenience Scores
Mothers
Most preferred (Score 2) 35 (19.8) 88 (49.7) 57 (32.2)
Less preferred (Score 1) 77 (43.5) 66 (37.3) 53 (29.9)
Not preferred (Score 0) 65 (36.7) 23 (13.0) 67 (37.9)
Mean scores for convenience ± (SD) 0.8 (0.7) 1.4 (0.7) 0.9 (0.8)
MCH Workers
Most preferred (Score 2) 10 (14.9) 31 (46.3) 32 (47..8)
Less preferred (Score 1) 40 (59.7) 35 (55.2) 25 (37.3)
Not preferred (Score 0) 17 (25.4) 1 (1.5) 10 (14.9)
Mean scores for convenience ± (SD) 0.9 (0.6) 1.4 (0.5) 1.3 (0.7)
All figures shown are N(proportion) unless otherwise indicated
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verse events related to any of the interventions used
during the course of study. The concentration of chlor-
hexidine used was equivalent to that used in prior trials
[13–15, 17, 26, 27]. All the three modes had the same
concentration of chlorhexidine (4 %) and the gel formu-
lation was thickened using hydroxy propyl methyl cellu-
lose. Both the gel and liquid formulations were
produced by Galentic Pharma (India) Pvt. Ltd. and made
available at a low cost of ~ USD 0.02 per application.
Two studies conducted in Nepal which evaluated
the acceptability and ease of use of gel and liquid
chlorhexidine indicated that gel formulation was more
acceptable and a preferred approach by families overTable 3 Newborn care practices and mode of Chlorhexidine applica
Practices 1
Thermal care provided (N = 108) 2
Skin to skin contact (N = 158) 3
Child wrapped in clean cloth (N = 174) 3
Did not bath baby immediately after birth (N = 152) 3
Fed on colostrum (N = 153) 3
Figures shown are N(%)
N indicates the number of mothers/caregivers providing newborn care practiceliquid formulation [16, 17]. However, no information
on the choice of delivery container (100 ml bottle
with cotton swab or 10 ml dropper bottle) was pro-
vided for chlorhexidine liquid solution application.
There can also be a possibility in those studies that
the participants failed to express negative concerns
about the intervention, anticipating better care. In
previously conducted trials in Nepal, Bangladesh and
Pakistan, chlorhexidine was applied using wipes, cot-
ton balls or syringes [15, 17, 28, 29].
Information collected through TIPs helped in selection
and implementation of a culturally acceptable interven-
tion for the main trial ‘evaluating the efficacy of use of
chlorhexidine to clean umbilical cord of neonates in firsttion preference
00 ml 10 ml Gel
0 (18.6) 44 (40.7) 44 (40.7)
2 (20.3) 73 (46.2) 53 (33.5)
8 (21.8) 76 (43.7) 60 (34.5)
1 (20.4) 73 (48.0) 48 (31.6)
6 (23.5) 67 (43.8) 50 (32.7)
















Mode of Delivery Preference stratified by 
randomization sequence 
100ml 10ml Gel
Fig. 1 Preference for mode of Chlorhexidine application stratified by randomization sequence. *Values depict numbers
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tis (Clinical Trial Number: ClinicalTrials.gov
NCT01528852)’. Based on the choice of mothers, hos-
pital staff and TBA/MCH, the 10 ml single use dropper
bottle was selected for the RCT.
Conclusion
It is the first trial of its kind reporting mothers/care-
takers and health professionals’ acceptability and prefer-
ence for various possible modes of chlorhexidine
delivery for cord care. 10 ml single use dropper bottle
was given highest preference for delivery of intervention.
In wake of current effort to scale up chlorhexidine cord
care interventions in various countries, with appropriate
changes in WHO recommendation for cord care, our
pilot study has lot of relevance for the programs intend-
ing to implement chlorhexidine interventions for reduc-
tion in omphalitis and neonatal mortality. Selection of
the most acceptable method of intervention delivery is
essential to the design and implementation of the inter-
vention efficacy trials as well as successful implementa-
tion of programs.
Abbreviations
CHX: Chlorhexidine; TIPs: Trials of Improved Practices; TBA: Trained birth
attendants; MCH: Maternal and child health; SES: Socio-economic status;
SPSS: Statistical Package for the Social Sciences.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
UD, SS and REB were involved in the conceptualization of research,
development of study protocol and questionnaires, and the preparation of
manuscript. PD helped with the development of study questionnaires,
interpretation of data and manuscript writing. AD and SD assisted with
development of study tools, field management, data analyses, interpretation
of results, and contributed to the text of the manuscript. Both SMAs helped
with adaptation of methods, Pemba study administration, community
mobilization and provided leadership and supervision to field teammembers. AMS helped with data collection and supervision in the field and
reviewed the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by the Bill & Melinda Gates Foundation. We are
grateful to the mothers, TBAs, MCH and hospital staff for their participation,
time and co-operation. We also thank the Ministry of Health, Government of
Zanzibar, Tanzania, for providing guidance and physical support at every
stage of the study; The Public Health Laboratory- Ivo de Carneri, as a
collaborating institution, for contributing towards management and
community relations, and providing infrastructural support. We duly
acknowledge the contribution of Galentic Pharma (India) Pvt. Ltd for
providing chlorhexidine and ensuring delivery on time. We further certify
that neither the funding agency nor the pharmaceutical company had any
role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Author details
1Department of International Health, E5521, Johns Hopkins Bloomberg
School of Public Health, 615, North Wolfe Street, Baltimore, MD 21205-203,
USA. 2Public Health Laboratory-Ivo de Carneri, Wawi, Chake-Chake, Pemba,
Zanzibar, Tanzania. 3Center for Public Health Kinetics, New Delhi, India.
Received: 2 March 2015 Accepted: 23 November 2015
References
1. Lawn JE, Cousens S, Zupan J. Four million neonatal deaths: when? Where?
Why? Lancet. 2005;365:891–900.
2. Schuchat A, Ziwicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sulliva MJ,
et al. For the PENS study group. Risk factors and opportunities for
prevention of early onset neonatal sepsis: a multicentre case control study.
Pediatrics. 2000;105:21–6.
3. Lawn JE, Kinney MV, Black RE, Pitt C, Cousens S, Kerber K, et al. Newborn
survival: a multi-country analysis of a decade of change. Health Policy Plan.
2012;27 Suppl 3:iii6–iii28.
4. Oestergaard MZ, Inoue M, Yoshida S, Mahanani WR, Gore FM, Cousens S,
et al. Neonatal mortality levels for 193 countries in 2009 with trends since
1990: a systemic analysis of progress, projections and priorities. PLoS Med.
2011;8:e1001080.
5. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4
million neonatal deaths in the year 2000. Int J Epidemiol. 2006;35(3):706–18.
Epub 2006 Mar 23.
6. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, WHO Child Health
Epidemiology Reference Group. WHO estimates of the causes of death in
children. Lancet. 2005;365:1147–52.
Dhingra et al. BMC Pregnancy and Childbirth  (2015) 15:354 Page 8 of 87. World Health Organization. Care of the umbilical cord. WHO/FHE/MSM-cord
care. Geneva: WHO; 1998 [Context Link].
8. McClure EM, Goldenberg RL, Brandes N, Darmstadt GL, Wright LL, CHX
Working Group et al. The use of chlorhexidine to reduce maternal and
neonatal mortality and morbidity in low-resource settings. Int J Gynaecol
Obstet. 2007;97:89–94.
9. Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of
vaginally administered chlorhexidine during labor to improve pregnancy
outcomes. Obstet Gynecol. 2006;107:1139–46.
10. Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine
antisepsis interventions for improving neonatal health in developing
countries. Pediatr Infect Dis J. 2006;25:665–75.
11. Denton GW. Chlorhexidine. In: Block SS, editor. Disinfection, sterilization, and
preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkens; 2001. p. 321–6.
12. World Health Organization. WHO Recommendations on Postnatal Care of
the Mother and Newborn. 2013. http://apps.who.int/iris/bitstream/10665/
93143/1/EMLc_4_eng.pdf.
13. Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerg SC, Shrestha S, et al.
Topical applications of chlorhexidine to the umbilical cord for prevention of
omphalitis and neonatal mortality in southern Nepal: a community-based,
cluster-randomised trial. Lancet. 2006;367:910–8.
14. Arifeen SE, Mullany LC, Shah R, Mannan I, Rahman SM, Talukder MR, et al.
The effect of cord cleansing with chlorhexidine on neonatal mortality in
rural Bangladesh: a community-based, cluster-randomised trial. Lancet.
2012;379(9820):1022–8.
15. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA. Topical application
of chlorhexidine to neonatal umbilical cords for prevention of omphalitis
and neonatal mortality in a rural district of Pakistan: a community-based,
cluster-randomised trial. Lancet. 2012;379(9820):1029–36.
16. Tuladhar S, Ban B. A study on cord-care practices in bardiya district, vol. 52.
Kathmandu: Nepal Family Health Program; 2007.
17. Hodgins S, Thapa K, Khanal L, Aryal S, Suvedi BK, Baidya U, et al.
Chlorhexidine gel versus aqueous for preventive use on umbilical stump: a
randomized noninferiority trial. Pediatr Infect Dis J. 2010;29(11):999–1003.
18. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional,
and national causes of child mortality: n updated systematic analysis for 2010
with time trendssince 2000. Lancet. 2012;379(9832):2151–61. doi:10.1016/
S0140-6736(12)60560-1. Epub 2012 May 11.
19. World Health Organization. Review of the available evidence on 4%
chlorhexidine solution for umbilical cord care. Second meeting of the
subcommittee of the expert committee on the selection and use of
essential medicines. Geneva: WHO; 2008.
20. Zupan J, Garner P, Omari AAA. Topical umbilical cord care at birth.
Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001057.
doi:0.1002/14651858.CD001057.pub2.
21. Hyder AA, Wali S, McGuckin J. Burden of disease for neonatal mortality in
South Asia and Sub-Saharan Africa. Washington, DC: Save the Children
Federation-U.S; 2001. p. 1–93.
22. The Manoff Group. Trials of Improved Practices (TIPs). [homepage on the
Internet]. [cited 2015Oct 8]. Available: http://www.manoffgroup.com/
resources/summarytips.pdf
23. Dhingra U, Gittelsohn J, Suleiman AM, Suleiman SM, Dutta A, Ali SM, et al.
Delivery, immediate newborn and cord care practices in Pemba Tanzania: a
qualitative study of community, hospital staff and community level care
providers for knowledge, attitudes, belief systems and practices. BMC
Pregnancy Childbirth. 2014;14:173.
24. Mullany LC, Faillace S, Tielsch JM, Stolzfus RJ, Nygaard KE, Kavle JA, et al.
Incidence and risk factors for newborn umbilical cord infections on Pemba
Island, Zanzibar, Tanzania. Pediatr Infect Dis J. 2009;28(6):503–9.
25. Alam MA, Ali NA, Sultana N, Mullany LC, Teela KC, Khan NU, et al. Newborn
umbilical cord and skin care in Sylhet District, Bangladesh: implications for
the promotion of umbilical cord cleansing with topical chlorhexidine.
J Perinatol. 2008;28 Suppl 2:S61–8. doi:10.1038/jp.2008.164.
26. Mullany LC, Saha SK, Shah R, Islam MS, Rahman M, Islam M, Talukder RR, El
Arifeen S, Darmstadt GL, Baqui AH. Impact of 4.0 % Chlorhexidine Cord
Cleansing on the Bacteriological Profile of the Newborn Umbilical Stump in
Rural Sylhet District, Bangladesh: A Community-Based, Cluster-Randomized
Trial. Pediatr Infect Dis J. 2011 Dec 20. [Epub ahead of print].
27. Mullany LC, El Arifeen S, Winch PJ, Shah R, Mannan I, Rahman SM, et al.
Impact of 4.0 % chlorhexidine cleansing of the umbilical cord on mortalityand omphalitis among newborns of Sylhet, Bangladesh: design of a
community-based cluster randomized trial. BMC Pediatr. 2009;9:67.
28. Darmstadt GL, Hossain MM, Choi Y, Shirin M, Mullany LC, Islam M, et al.
Safety and effect of chlorhexidine skin cleansing on skin flora of neonates in
Bangladesh. Pediatr Infect Dis J. 2007;26:492–5.
29. Mullany LC, Khatry SK, Sherchand JB, LeClerq SC, Darmstadt GL, Katz J, et al.
A randomized controlled trial of the impact of chlorhexidine skin cleansing
on bacterial colonization of hospital-born infants in Nepal. Pediatr Infect Dis
J. 2008;27(6):505–11.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
